Article View: be.science
Article #467Cancer - Press Review (March 23, 2013) – Revue de presse (23 mars 2013)
From: SMW
Date: Fri, 22 Mar 2013 17:43
Date: Fri, 22 Mar 2013 17:43
153 lines
7044 bytes
7044 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (March 23, 2013) – Revue de presse (23 mars 2013) Breast cancer drug does not provide value for money, regulator rules Charity expresses disappointment after Nice rules everolimus should not be available for widespread NHS use. In The Guardian http://www.guardian.co.uk/society/2013/mar/21/breast-cancer-drug-value-regulator Gene Therapy Spurs Leukemia Hope Researchers reported fresh evidence Wednesday that using gene therapy to manipulate the immune system is emerging as a promising new strategy in the fight against cancer. By Ron Winslow. The Wall Street Journal http://online.wsj.com/article/SB10001424127887324373204578372522311665466.html New Imaging Agent Enables Better Cancer Detection, More Accurate Staging Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes. In UCSD Medical Center http://health.ucsd.edu/news/releases/Pages/2013-03-20-imaging-dye-for-breast-cancer-surgery.aspx Iraq War Anniversary: Birth Defects And Cancer Rates At Devastating High In Basra And Fallujah (VIDEO) Ten years after the start of the U.S. invasion in Iraq, doctors in some of the Middle Eastern nation's cities are witnessing an abnormally high number of cases of cancer and birth defects. Scientists suspect the rise is tied to the use of depleted uranium and white phosphorus in military assaults. By Eline Gordts. In Huffington Post http://www.huffingtonpost.com/2013/03/20/iraq-war-anniversary-birth-defects-cancer_n_2917701.html Cancer Research Technology and The Institute of Cancer Research enter collaboration with Janssen to discover multiple myeloma drug Multiple myeloma is the third most common type of blood cancer, with around 4,700 new cases and around 2,600 deaths each year in the UK. It is often effectively treated initially but many patients become resistant to treatment, and there is an urgent need for new therapies. In Cancer Research UK http://www.cancerresearchuk.org/cancer-info/news/archive/pressrelease/2013-03-20-Janssen-ICR-CRT Genetics May Be Tied to Breast Cancer Risk in Unexpected Ways Scientists found new connections among genes, hormone sensitivity and fat. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2013/03/19/genetics-may-be-tied-to-breast-cancer-risk-in-unexpected-ways On Surviving a Brain Cancer Death Sentence Valerie Harper received a death sentence. Just like my father. And while I hope that she lives as long as she can, comfortably and with dignity, "surviving" these types of cancer does not always mean what we would like it to. By Davis Schneiderman. In Huffington Post http://www.huffingtonpost.com/davis-schneiderman/surviving-cancer_b_2901592.html Dépister un cancer grâce à une prise de sang ? Le dépistage précoce d’un cancer est fondamental dans le traitement de la maladie. Néanmoins, malgré les prouesses technologiques dans le domaine de l’imagerie médicale, la détection d’un cancer est parfois trop tardive. Une étude récente montre que l’on peut directement identifier des facteurs tumoraux dans le sang. Se dirige-t-on vers le dépistage grâce à une simple prise de sang ? Par Agnès Roux. Dans Futura Sciences http://www.futura-sciences.com/fr/news/t/genetique-1/d/depister-un-cancer-grace-a-une-prise-de-sang_45228/ Cancer du sein : mesdames, méfiez-vous du lait entier, il augmenterait les risques de mortalité Selon une étude américaine, les femmes en rémission d'un cancer du sein doivent éviter de consommer trop de produits laitiers à base de lait entier. Dans Atlantico.fr http://www.atlantico.fr/pepites/cancer-sein-mesdames-mefiez-lait-entier-augmenterait-risques-mortalite-672447.html CANCER: 7 règles de vie pour réduire son risque de 50% Ces 7 mesures pourraient réduire de moitié le risque de développer un cancer, selon cette grande étude américaine. Dans Santé Log http://www.santelog.com/news/cancerologie/cancer-7-regles-de-vie-pour-reduire-son-risque-de-50-_10091.htm CANCER: Une protéine du poisson inhibe les métastases Une protéine de poisson capable d’inhiber les métastases du cancer, c’est ce que viennent de découvrir ces chercheurs de l’Université du Maryland. Dérivé de la morue du Pacifique, ce composé naturel à l’activité anti-tumorale pourrait permettre de développer des aliments qui agissent comme des traitements complémentaires contre le cancer. Ces conclusions viennent d’être publiées dans l’édition des Actes de l’Académie des Science américaine (PNAS). Dans Santé Log http://www.santelog.com/news/cancerologie/cancer-une-proteine-du-poisson-inhibe-les-metastases_10097.htm Plus que jamais, le cancer appauvrit Selon le constat alarmant de l'Observatoire sociétal des malades de la Ligue contre le cancer, "les malades n'arrivent plus à financer le quotidien". Dans Le Point http://www.lepoint.fr/societe/plus-que-jamais-le-cancer-appauvrit-21-03-2013-1643634_23.php Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix-Corman – InTextoResearch – Baelen (03/2013)
Technical Details
Message-ID:
<8e566206-7112-4e46-a037-8e4024ea6734@k8g2000yqb.googlegroups.com>Path:
arc1-ca.pugleaf.net!k8ni11100qas.0!nntp.google.com!ca1no1196346qab.0!postnews.google.com!k8g2000yqb.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: a254ea4a8d,7b6d8b7671ca3d1a,start
X-Google-Attributes: gida254ea4a8d,public,usenet
X-Google-NewGroupId: yes
X-Google-Language: ENGLISH,CP1252
X-Received: by 10.224.219.146 with SMTP id hu18mr719147qab.3.1363974225442;
Fri, 22 Mar 2013 10:43:45 -0700 (PDT)
MIME-Version: 1.0
X-Received: by 10.49.97.166 with SMTP id eb6mr193655qeb.0.1363974225412; Fri,
22 Mar 2013 10:43:45 -0700 (PDT)
Path: arc1-ca.pugleaf.net!k8ni11100qas.0!nntp.google.com!ca1no1196346qab.0!postnews.google.com!k8g2000yqb.googlegroups.com!not-for-mail
Newsgroups: be.science
Date: Fri, 22 Mar 2013 10:43:45 -0700 (PDT)
Complaints-To: groups-abuse@google.com
Injection-Info: k8g2000yqb.googlegroups.com; posting-host=87.64.42.12; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
NNTP-Posting-Host: 87.64.42.12
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.22 (KHTML, like
Gecko) Chrome/25.0.1364.172 Safari/537.22,gzip(gfe)
Message-ID: <8e566206-7112-4e46-a037-8e4024ea6734@k8g2000yqb.googlegroups.com>
Subject: Cancer - Press Review (March 23, 2013) – Revue de presse (23 mars 2013)
From: SMW <scimedweb@mail.com>
Injection-Date: Fri, 22 Mar 2013 17:43:45 +0000
Content-Type: text/plain; charset=windows-1252
Content-Transfer-Encoding: quoted-printable